These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16250850)

  • 1. PET imaging in clinical drug abuse research.
    Gatley SJ; Volkow ND; Wang GJ; Fowler JS; Logan J; Ding YS; Gerasimov M
    Curr Pharm Des; 2005; 11(25):3203-19. PubMed ID: 16250850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging the neurochemistry of alcohol and substance abuse.
    Martinez D; Kim JH; Krystal J; Abi-Dargham A
    Neuroimaging Clin N Am; 2007 Nov; 17(4):539-55, x. PubMed ID: 17983969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET imaging for addiction medicine: From neural mechanisms to clinical considerations.
    Wiers CE; Cabrera E; Skarda E; Volkow ND; Wang GJ
    Prog Brain Res; 2016; 224():175-201. PubMed ID: 26822359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET imaging studies in drug abuse.
    Fowler JS; Volkow ND
    J Toxicol Clin Toxicol; 1998; 36(3):163-74. PubMed ID: 9656971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography and single-photon emission computed tomography in substance abuse research.
    Volkow ND; Fowler JS; Wang GJ
    Semin Nucl Med; 2003 Apr; 33(2):114-28. PubMed ID: 12756644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging Tobacco Smoking with PET and SPECT.
    Cosgrove KP; Esterlis I; Sandiego C; Petrulli R; Morris ED
    Curr Top Behav Neurosci; 2015; 24():1-17. PubMed ID: 25638332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain imaging studies of cocaine abuse: implications for medication development.
    London ED; Bonson KR; Ernst M; Grant S
    Crit Rev Neurobiol; 1999; 13(3):227-42. PubMed ID: 10803636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug dependence and addiction, III: Expectation and brain function in drug abuse.
    Volkow N
    Am J Psychiatry; 2004 Apr; 161(4):621. PubMed ID: 15056504
    [No Abstract]   [Full Text] [Related]  

  • 9. [Outlines of interdisciplinary addiction research given by the example of medical imaging with PET, SPECT and fMRI regarding effects of psychotropic substances].
    Giacomuzzi SM; Golaszewski S; Ertl M; Riemer Y; Brandauer E; Ennemoser O; Rössler H; Hinterhuber H
    Neuropsychiatr; 2010; 24(4):224-33. PubMed ID: 21176703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging receptor changes in human drug abusers.
    Cosgrove KP
    Curr Top Behav Neurosci; 2010; 3():199-217. PubMed ID: 21161754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography as a tool for studying alcohol abuse.
    Thanos PK; Wang GJ; Volkow ND
    Alcohol Res Health; 2008; 31(3):233-7. PubMed ID: 23584865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging neurotransmitter release by drugs of abuse.
    Martinez D; Narendran R
    Curr Top Behav Neurosci; 2010; 3():219-45. PubMed ID: 21161755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain Volume Correlates with Duration of Abstinence from Substance Abuse in a Region-Specific and Substance-Specific Manner.
    Korponay C; Kosson DS; Decety J; Kiehl KA; Koenigs M
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2017 Oct; 2(7):626-635. PubMed ID: 29308437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relation between gray matter volume and the use of alcohol, tobacco, cocaine and cannabis in male polysubstance users.
    Kaag AM; Schulte MHJ; Jansen JM; van Wingen G; Homberg J; van den Brink W; Wiers RW; Schmaal L; Goudriaan AE; Reneman L
    Drug Alcohol Depend; 2018 Jun; 187():186-194. PubMed ID: 29679913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the treatment of drug abuse with molecular imaging.
    Schiffer WK; Liebling CN; Patel V; Dewey SL
    Nucl Med Biol; 2007 Oct; 34(7):833-47. PubMed ID: 17921034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography molecular imaging of dopaminergic system in drug addiction.
    Hou H; Tian M; Zhang H
    Anat Rec (Hoboken); 2012 May; 295(5):722-33. PubMed ID: 22467195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonhuman primate positron emission tomography neuroimaging in drug abuse research.
    Howell LL; Murnane KS
    J Pharmacol Exp Ther; 2011 May; 337(2):324-34. PubMed ID: 21317354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroimaging in drug abuse.
    Lindsey KP; Gatley SJ; Volkow ND
    Curr Psychiatry Rep; 2003 Oct; 5(5):355-61. PubMed ID: 13678555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy of dual substance abuse and dependence.
    Kenna GA; Nielsen DM; Mello P; Schiesl A; Swift RM
    CNS Drugs; 2007; 21(3):213-37. PubMed ID: 17338593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Electronic Cigarettes Leads to Significant Beta2-Nicotinic Acetylcholine Receptor Occupancy: Evidence From a PET Imaging Study.
    Baldassarri SR; Hillmer AT; Anderson JM; Jatlow P; Nabulsi N; Labaree D; Cosgrove KP; O'Malley SS; Eissenberg T; Krishnan-Sarin S; Esterlis I
    Nicotine Tob Res; 2018 Mar; 20(4):425-433. PubMed ID: 28460123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.